Preparing for Audit and Regulatory Inspections

Budapest, June 21-22, 2012

What do you do when the EMA or the FDA comes knocking? Are you absolutely confident that everyone is fully prepared? Every clinical trial is subject to audits as well as health authority inspections from time to time, verifying compliance with rigorous requirements that have in fact changed significantly over the last few years. In this masterclass you will learn, develop and practice what you need, to be ready when the call comes, taking you through from the announcement to the end of the process.

PHARM Connect Congress 2013

February, 27- 28th 2013

The Annual PHARM Connect Congress for Enlarged Europe is one of the largest pharmaceutical and biotechnology manufacturing events in Central and Eastern Europe and the CIS market in 2013.

The event is bringing together around 500 senior decision-makers from Europe’s leading pharmaceuticals and biotechnology companies, giving them the opportunity to share their knowledge and discuss their key priorities.

Troostwijk Auctions have announced the final auction of forensic science and laboratory equipment for the Forensic Science Service (FSS). The fifth and final auction sale will be conducted online with lots closing on 24^th May 2012. The forensic science equipment can be viewed on 17^th May, by appointment in Barnsley UK.

India’s Marketing Regulations of Drugs

Approval of the drug product for import, manufacturing and marketing in India, its demonstration for safety and efficacy in humans is essential. The Rules 122A, 122B and 122D, 122 DA, 122DAA, 122E and Appendix I, IA and VI of Schedule Y of the Drugs & Cosmetics Act, 1945, describes the information/data required for approval of clinical trial and/or to import, manufacture, or market any new drug in the country. However, the requirements for approval of clinical trials and new drugs may vary depending on the nature of new drugs.

The whole 12 pages article is available for download at Downloads section of Farmavita.Net.

Pharma Excellence in the CEE, CIS, SEE and Turkey

4 - 5th, June 2012 

 Tightening regulations, increasing healthcare costs, ever-growing budget restrictions - these are just a few of the concerns that are raising the attention of key pharma stakeholders throughout the region of CEE, CIS, SEE countries and Turkey. In this new market reality, pharma companies still need to find a way to capture maximum business potential in these key regions. 

Natural products as a gold mine for arthritis treatment

Arthritis, an inflammation of the joints, is usually a chronic disease that results from dysregulation of pro-inflammatory cytokines (e.g. tumour necrosis factor and interleukin-1b) and pro-inflammatory enzymes that mediate the production of prostaglandins (e.g. cyclooxygenase-2) and leukotrienes
(e.g. lipooxygenase), together with the expression of adhesion molecules and matrix metalloproteinases, and hyperproliferation of synovial fibroblasts. All of these factors are regulated by the activation of the transcription factor nuclear factor-kB. Thus, agents that suppress the expression of tumour necrosis factor-a, interleukin-1b, cyclooxygenase-2, lipooxygenase, matrix metalloproteinases or adhesion molecules, or suppress the activation of NF-kB, all have potential for the treatment of arthritis.

The whole 8 pages article is available for download at Downloads section of Farmavita.Net. 

CEO Todd Blonshine Featured Speaker in Two Tracks

(Research Triangle Park, N.C.) Mustard Tree Instruments® , continuing to lead the way in developing innovative solutions to evolving pharmaceutical and chemical manufacturing challenges, shared best practices and new products to address quality control issues at the major industry tradeshow Pittcon 2012, the world’s largest annual conference and exposition for laboratory science March 11-16.

2nd Annual Orphan Drug Congress 2012

7-8, June 2012

This year's conference will discuss the major concerns, newest challenges and the best practices in the development of orphan drugs. The use of patient registries, open innovation in rare diseases, designation, the importance of communication between pharma, patients and HTA bodies, use of social media and many more will be covered by the au fait pharmaceutical representatives. 

6th Annual Licensing in Generics

30 – 31 May 2012

In the framework of this conference, the current market trends in the global generic business development and licensing will be discussed and the best practices in managing intellectual property challenges will be introduced. The worldwide pharmaceutical experts will reveal the opportunities in rising markets for generic licensing activities in their case studies.

Clinical Commercial Payer Forum

May 8^th and 9^th, Zurich

Prove payer value during early drug development

• Build commercial endpoints into clinical trials – Novartis and the best of big pharma share how payer insight has provided robust development plans.
• Enable clinical and commercial teams to work together toward joint goals – with cases from Baxter, GSK and Celgene.
• Enhance your solutions for unmet need with Real World Data. Hear from the ABPI Task Force.
• Comparative Effectiveness Research – find out how pharma companies and payers are working together to build clinical studies that prove value and align to un-met need.

(Durham, N.C.) Trig® Innovation, a Research Triangle, NC-based innovation management firm, recently completed a unique 3D animation video project for its client Mustard Tree Instruments®, an analytical instrumentation company developing innovative solutions to evolving pharmaceutical and chemical manufacturing challenges.

(Morrisville, N.C.) Full-service advertising and branding firm The Marketing Machine recently finished an ambitious, innovative rebranding project for Danadams Pharmaceuticals Industry Limited to help overcome literacy and distribution challenges with patients in Ghana, South Africa. The firm utilized its award-winning design services team to redesign all of Danadams branding and packaging using intuitive visual icons and color elements to indicate the type of drugs and dosages and better display information more clearly and legibly.
 

Pharmaceutical and Medical Device Market Access in Key Asian Markets 

 23rd- 24th May 2012, Singapore

Huge array of forensic science equipment up for auction

Troostwijk Auctions conducted a huge auction sale on behalf of Forensic Science Service (FSS) in March 2011 and have been appointed to manage the final phase of the asset disposal. The first auction sale is scheduled for 29th February.  A further sale is anticipated in the spring.

2012 Pharma CI Conference & Exhibition

September 11-12, 2012, USA

The Pharma CI Conference & Exhibition (September 11-12, 2012, Parsippany, NJ) is THE INDUSTRY'S GOLD STANDARD for senior level pharmaceutical, biotechnology, medical device, and diagnostics professionals seeking the latest news and the rare chance to network with all the industry's luminaries. More than 300 people came in 2011! This is the biggest and best gathering of pharmaceutical competitive intelligence thought leaders (75+ speakers)!

Doctors 2.0™ & You

THE HealthCare Social Media and Web 2.0 Conference!

May 23-24 2012, Paris

Over a full two day programme, including a Cocktail Soirée in a private, historical venue, Doctors 2.0 & You will highlight: how doctors and other healthcare professionals, patients, hospitals, government, pharma, and payers use Social Media, mobile apps, and Web 2.0 tools to connect and the best practices that emerge for each. Ask our prestigious Advisory Board ! Below are 4 reasons why you should not miss Doctors 2.0 & You in 2012.

Brisco Harward, Ph.D. Addresses New York Section of the Society for Applied Spectroscopy (NYSAS)

(Research Triangle Park, N.C.) Mustard Tree Instruments®, an innovator in analytical instrumentation for the pharmaceutical manufacturing industry, is pleased to announce that Science Officer Brisco Harward Ph.D. addressed members of the NY Section of the Society for Applied Spectroscopy (NYSAS) on November 9, 2011.